-
Drug Delivery
Salon D
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
Evening Drinks Reception
-
Drug Delivery
Salon D
Delivery approaches for CNS indications Targeting to CNS Full CNS exposure Specific targeting within
...
-
Preclinical
Salon B
-
Clinical Studies
Salon C
-
Preclinical
Salon B
-
Clinical Studies
Salon C
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
Salon H
-
Novel Targets
Salon A
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
1-2-1 Meetings / Networking Break
1-2-1 Meetings (Salon E/G) | Networking Break (Grand Foyer)
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
1-2-1 Meetings / Networking Break
1-2-1 Meetings (Salon E/G) | Networking Break (Grand Foyer)
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
Salon H
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
Networking Lunch
Salon G
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
Registration
Grand Foyer
-
Clinical Studies
Salon C
-
Preclinical
Salon B
-
Novel Targets
Salon A
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
Morning Refreshments
Grand Foyer
-
Preclinical
Salon B
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
1-2-1 Meetings / Networking Break
1-2-1 Meetings (Salon E/G) | Networking Break (Grand Foyer)
-
Drug Delivery
Salon D
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
1-2-1 Meetings / Networking Break
1-2-1 Meetings (Salon E/G) | Networking Break (Grand Foyer)
-
Clinical Studies
Salon C
-
Novel Targets
Salon A
-
-
Drug Delivery
-
Novel Targets
-
Preclinical
-
Clinical Studies
Salon H
![Sponsor Led Roundtable: Utilizing Innovative Strategies and Collaborations to Address Challenges in Neurodegenerative Trials [Clinical Studies Topic]](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/partners/Biorasi.png/fit-in/500x9999/filters:no_upscale())
)
)
)
![Poster Presentation: CNS-Targeted Therapies Delivery Strategies and Sampling in Non-Rodent Preclinical Species: Considerations During Early Phase Discovery to IND-Enabling Regulatory Studies [Preclinical Topic]](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/experts/Altasciences.png/fit-in/500x9999/filters:no_upscale())
)
)
)
![Sponsor Led Roundtable: Histology and IHC in CNS Drug Discovery: 2D or 3D? [Preclinical Topic]](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/partners/Translucence-Bio.png/fit-in/500x9999/filters:no_upscale())
)
)
)
)
)
)
)
)
)
)
)
)
)